Ibex: Our AI Algorithm to Aid Pathologists with Accurate and Reproducible HER2 and HER2-low Assessment in Breast Cancer Diagnosis TEL AVIV, Israel, Jan. 24, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer...

Ibex: NHS Trusts Gain Access to Galen, Ibex's Multi-tissue AI Platform, Supporting Pathologists with Enhanced Diagnostic Accuracy and Efficiency TEL AVIV, Israel, and LONDON, Dec. 7, 2022 /PRNewswire/ -- Ibex Medical Analytics (Ibex),...

Ibex: Kreos Capital, a leading growth debt provider, invests $10 million to accelerate Ibex's AI deployments and new customers, paving way for further expansions TEL AVIV, Israel, Nov. 9, 2022 /PRNewswire/ --  Ibex Medical...

Proscia invites you to join them for a live virtual panel discussion. Title: Panel Discussion: The Use of AI in Routine, High-Throughput Workflows Date: Tuesday, August 30, 2022 Time: 11:00 AM Eastern Daylight Time Duration: 1...

Expanded menu of innovative AI-powered decision support tools benefits pathologists and patients through enhanced quality of diagnosis Joint development to distribute an embedded image analysis workflow for pathologists to seamlessly access...

Ibex was selected among the first ever winners of the AI in Health and Care Award, sharing £50 million to enable a study of Ibex’s AI technology across multiple NHS trusts Tel Aviv, Israel - September 22, 2020 - Ibex Medical Analytics,...